UH-AC62MU

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UH-AC62MU, covering 2014-07-08 to 2014-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Influence of a High Fat Breakfast in the Pharmacokinetics of UH-AC62MU in Healthy Subjects [Phase 1]